Plasma CTSS levels provided high discriminatory accuracy values on diagnosing OSA; it might be a potential biomarker with a positive diagnostic value for inflammatory reactions in patients with OSA&T2D. This evidence concerns the gene CTSS and obstructive sleep apnea syndrome.